The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 12,370.00
Ask: 12,374.00
Change: 38.00 (0.31%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-London's FTSE 100 drops to near one-month low as lockdown fears weigh

Thu, 28th Jan 2021 09:24

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* UK demands AstraZeneca to deliver ordered vaccines

* Car output falls to lowest level since 1984

* Prudential drops on demerger and equity raise plans

* FTSE 100 falls 0.6%, FTSE 250 adds 0.4%
(Updates to close)

By Shashank Nayar and Amal S

Jan 28 (Reuters) - The FTSE 100 hit a near one-month
low on Thursday as energy stocks tracked commodity prices lower
following virus and lockdown-led demand worries, while the
vaccine row between the European Union and AstraZeneca Plc
continued to weigh.

AstraZeneca was the second biggest drag on the FTSE
100 index as Britain demanded it must receive all the COVID-19
vaccines it had ordered, while the EU warned drug companies that
it would use all legal means or even block exports unless they
agreed to deliver shots as promised.

The blue-chip FTSE 100 index fell 0.6% with insurer
Prudential being the top drag after it said it would
separate its U.S. business Jackson through a demerger and may
raise $2.5 billion to $3 billion in new equity.

"It's a very speculative bubble of a market that has
definitely led to people suggesting for a pullback," said Keith
Temperton, an equity sales trader at Forte Securities.

"So, in my view, it's a long overdue pullback and nothing to
be alarmed about particularly, but rather just an expected
market reaction for London."

Higher virus cases and lockdowns led the UK to its biggest
rise in vacant shops in over two decades, while car output fell
to its lowest level since 1984.

The export-heavy FTSE 100 has recorded consistent monthly
gains since Novemeber, but recently lost steam as rising cases
and lockdowns led British households to cut expenses while the
proportion of workers on furlough rose to its highest since
July.

British airline easyJet gained 4.6% even as it warned that
its prospect had worsened for the January-March quarter.
London-listed shares of Hungarian airline Wizz Air
jumped 4.7% after it vowed to use the coronavirus crisis to grab
business from rivals including easyJet.

Miner Anglo American slipped 3.9% after it trimmed
its 2021 production outlook for diamonds, but it kept output
targets for most other metals unchanged.
(Reporting by Shashank Nayar in Bengaluru; editing by
Uttaresh.V and Richard Chang)

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.